TORONTO, Feb. 28,
2025 /PRNewswire/ -- In the context of the global
economy's digital transformation, Artificial Intelligence (AI) has
emerged as a pivotal force driving productivity growth. According
to IDC's latest report, AI is expected to contribute up to
$19.9 trillion to the global economy
by 2030, equivalent to 3.5% of the global GDP. Among these
advancements, Generative AI, with its ability to produce creative
outputs, is ushering in the fourth productivity
revolution—following the eras of the steam engine, electricity, and
computers. As a Nasdaq-listed company (Stock Code: GV), Visionary
Holdings has emerged as a leader in this technological
transformation, achieving groundbreaking progress in FinTech,
digital currencies, and biotechnology through deep research and
development in generative AI.
In the FinTech and digital currency sectors, traditional
operational models face numerous challenges, particularly in
transaction processing delays and risk control compliance. The high
volatility of the digital currency market makes it difficult for
traditional matching engines to handle massive orders during peak
trading periods, causing delays that severely impact investor
decision-making. At the same time, increasingly stringent global
regulatory policies require FinTech companies to monitor abnormal
transactions in real time, a task for which traditional risk
control systems are often inadequate.
Visionary Holdings' generative AI technology has successfully
addressed these challenges. On its digital asset trading platform,
AI technology has optimized the matching engine, reducing
transaction delays by 40% and significantly improving execution
speed. Advanced machine learning models have achieved a
fraud detection rate of 97.5%, effectively mitigating
risks such as money laundering and hacker attacks. Additionally,
AI-powered deep analysis provides users with personalized
investment advice and optimal trading strategies, enhancing
profitability. Furthermore, the implementation of AI customer
service has reduced labor costs by 40% while increasing customer
satisfaction to 94.2% (2023 operational data), significantly
improving service quality.
The biotechnology sector also faces challenges, such as the
complexity of medical data processing and the difficulty of meeting
personalized healthcare needs. Traditional data analysis methods
are inefficient in handling data from gene sequencing, cancer
screening, and biochips, while limited medical resources hinder the
development of precise, personalized treatment plans. Visionary
Holdings' AI technology offers solutions to these issues. In cancer
screening and genetic testing, the AI-driven analysis of biochip
data for cervical cancer E7 protein detection has achieved a
sensitivity rate of 98.7% and has received FDA certification. In
intelligent drug development, AI accelerates the screening of new
drugs by analyzing cancer patients' genetic data, improving drug
matching rates and bringing breakthroughs in precision
medicine.
Visionary Holdings' intelligent AI system employs a unique
four-layer architecture to ensure efficient and intelligent
management. The Intelligent Perception
Layer supports multimodal inputs such as voice, text,
market data, and biochip data, providing real-time investment and
medical diagnostic recommendations through AI analysis.
The Cognitive Decision Layer includes an
intelligent risk control engine and a medical knowledge graph,
enabling real-time financial risk monitoring and the generation of
precise medical solutions. The Generative Execution
Layer features AI trading assistants and health
assistants, offering practical support services to users and
patients. The Autonomous Evolution Layer uses
reinforcement learning loops and human feedback optimization to
continuously improve AI model accuracy, ensuring recommendations
comply with regulatory and medical standards.
Looking ahead, the prospects for AI technology are vast.
Visionary Holdings will continue to lead industry trends by
promoting AI-driven financial compliance management, using natural
language understanding to automatically adapt to financial
regulations across countries and reduce compliance costs.
Additionally, the company will explore the integration of quantum
computing and AI to enable more complex financial modeling and
medical data analysis, further enhancing predictive
capabilities.
With the rapid advancement of AI technology, the global industry
is expected to enter a new era of intelligence in 2024. Visionary
Holdings, through its exceptional practices in generative AI, has
not only achieved significant growth for its own business but also
provided valuable insights for industry development, guiding the
FinTech and biotechnology sectors toward a smarter and more
efficient future.
For more information, please contact:
Visionary Holdings Inc.
Investor Relations Department
Email: ir@farvision.ca
View original
content:https://www.prnewswire.com/news-releases/visionary-holdings-generative-ai-leads-the-efficiency-revolution-reshaping-the-future-of-fintech-and-biotechnology-302383388.html
SOURCE Visionary Holdings Inc.
